{ "cik": 1583648, "cik_padded": "0001583648", "entityName": "PALVELLA THERAPEUTICS, INC.", "fiscal_years": [ { "accn": "0001193125-26-133372", "filed": "2026-03-31", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 57982000.0, "eps_diluted": -3.71, "net_income": -41715000.0, "operating_cash_flow": -25006000.0, "operating_income": -38602000.0, "stockholders_equity": 27983000.0, "total_assets": 59559000.0, "total_liabilities": 31576000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1283993853410998, "roa_avg2y": -0.5645057614366039, "roa_period_end": -0.7003979247468897, "roe_avg2y": -0.9209625786510652, "roe_period_end": -1.4907265125254618 } }, { "accn": "0001193125-26-133372", "filed": "2026-03-31", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 83602000.0, "eps_diluted": -7.83, "net_income": -17434000.0, "operating_cash_flow": -10840000.0, "operating_income": -14095000.0, "stockholders_equity": 62607000.0, "total_assets": 88234000.0, "total_liabilities": 25627000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.40933122494289775, "roa_avg2y": -0.36403499613706125, "roa_period_end": -0.19758823129405897, "roe_avg2y": 2.936005389019872, "roe_period_end": -0.2784672640439567 } }, { "accn": "0001193125-26-133372", "filed": "2026-03-31", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 7350000.0, "eps_diluted": 2.17, "net_income": 18691000.0, "operating_cash_flow": -13703000.0, "operating_income": -11869000.0, "stockholders_equity": -74483000.0, "total_assets": 7548000.0, "total_liabilities": 11428000.0 }, "period_end": "2023-12-31", "ratio_units": { "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": 0.36279819095867544, "roe_avg2y": -0.22216807322001664 } }, { "accn": "0000950170-25-047212", "filed": "2025-03-31", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 38635000.0, "net_income": -33277000.0, "operating_cash_flow": -59932000.0, "operating_income": -43474000.0, "stockholders_equity": -93777000.0, "total_assets": 95490000.0, "total_liabilities": 67561000.0 }, "period_end": "2022-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.26723147962256577, "roa_period_end": -0.348486752539533, "roe_avg2y": 1.5469759657849473 } }, { "accn": "0001437749-24-010123", "filed": "2024-03-29", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 117764000.0, "eps_diluted": -0.71, "net_income": -45738000.0, "operating_cash_flow": -7660000.0, "operating_income": -51831000.0, "stockholders_equity": 50755000.0, "total_assets": 153560000.0, "total_liabilities": 102805000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.025514727613043, "roa_avg2y": -0.35377654020187954, "roa_period_end": -0.2978510028653295, "roe_avg2y": -1.11853464087452, "roe_period_end": -0.9011525958033691 } }, { "accn": "0001583648-22-000016", "filed": "2023-03-31", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 70436000.0, "eps_diluted": -0.68, "net_income": -37230000.0, "operating_cash_flow": -45896000.0, "operating_income": -33921000.0, "stockholders_equity": 31027000.0, "total_assets": 105010000.0, "total_liabilities": 73983000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.3844715892609663, "roa_avg2y": -0.3025513292998574, "roa_period_end": -0.3545376630797067, "roe_avg2y": -0.9038711322060233, "roe_period_end": -1.199922648016244 } }, { "accn": "0001583648-22-000016", "filed": "2022-03-02", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 62260000.0, "net_income": -25469000.0, "operating_cash_flow": -52467000.0, "operating_income": -27157000.0, "stockholders_equity": 51352000.0, "total_assets": 141097000.0, "total_liabilities": 89745000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.7476437139741392, "roa_avg2y": -0.1803510859020387, "roa_period_end": -0.18050702708066083, "roe_avg2y": -0.5579984006485041, "roe_period_end": -0.49596899828633745 } }, { "accn": "0001583648-21-000005", "filed": "2021-03-31", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 74867000.0, "net_income": -26754000.0, "operating_cash_flow": -1066000.0, "operating_income": -30831000.0, "stockholders_equity": 39935000.0, "total_assets": 141341000.0, "total_liabilities": 101406000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.539276324026543, "roa_avg2y": -0.21820673118095402, "roa_period_end": -0.18928690188975597, "roe_avg2y": -1.0398585226499797, "roe_period_end": -0.6699386503067486 } }, { "accn": "0001583648-20-000015", "filed": "2020-03-13", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 37878000.0, "net_income": -17647000.0, "operating_cash_flow": 49754000.0, "operating_income": -14594000.0, "stockholders_equity": 11522000.0, "total_assets": 103876000.0, "total_liabilities": 92354000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 8.015448706821733, "roa_avg2y": -0.2540251477267002, "roa_period_end": -0.16988524779544842, "roe_avg2y": -0.9604070859070996, "roe_period_end": -1.531591737545565 } }, { "accn": "0001583648-19-000011", "filed": "2019-03-18", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 29356000.0, "net_income": -22799000.0, "operating_income": -22759000.0, "stockholders_equity": 25227000.0, "total_assets": 35063000.0, "total_liabilities": 9836000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3898997106275023, "roa_period_end": -0.650229586743861, "roe_period_end": -0.9037539144567329 } }, { "accn": "0001583648-14-000010", "filed": "2014-09-12", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "operating_cash_flow": "USD" }, "fundamentals": { "operating_cash_flow": -15062.0 }, "period_end": "2014-06-30", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-133372", "filed": "2026-03-31", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001583648.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001583648.json" }, "ticker": "PVLA" }